An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advance-Stage Parkinson's Disease

Completed · Phase 3

Conditions studied: Parkinson's Disease

In brief

The objective of this open-label extension is to assess the safety and tolerability of long-term treatment of the Rotigotine patch in subjects with advanced-stage idiopathic Parkinson's Disease.

Key facts

Study ID

NCT00594386

Run by

UCB Pharma

People needed

258

Starts

2002-08-01

Expected to finish

2008-12-01

Last updated by the study team

2014-10-02

Who can join

Age: 31 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subjects who have completed six months of maintenance treatment in the SP650 double-blind trial

You may not qualify if…

• Subjects who had an ongoing serious adverse event from the SP650 double-blind trial that was assessed as related to study medication

Where it is running

• Study site — Huntsville, Alabama, United States
• Study site — Peoria, Arizona, United States
• Study site — Phoenix, Arizona, United States
• Study site — Tucson, Arizona, United States
• Study site — Hot Springs, Arkansas, United States
• Study site — Fountain Valley, California, United States
• Study site — Fresno, California, United States
• Study site — Irvine, California, United States
• Study site — Los Angeles, California, United States
• Study site — Danbury, Connecticut, United States
• Study site — Fairfield, Connecticut, United States
• Study site — New Haven, Connecticut, United States
• Study site — Miami, Florida, United States
• Study site — Pompano Beach, Florida, United States
• Study site — St. Petersburg, Florida, United States
• Study site — Sunrise, Florida, United States
• Study site — Atlanta, Georgia, United States
• Study site — Hoffman Estates, Illinois, United States
• Study site — Fort Wayne, Indiana, United States
• Study site — Kansas City, Kansas, United States
• Study site — Lexington, Kentucky, United States
• Study site — Boston, Massachusetts, United States
• Study site — Southfield, Michigan, United States
• Study site — Minneapolis, Minnesota, United States
• Study site — Henderson, Nevada, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.